The Clorox Company (NYSE:CLX) Shares Sold by Vinva Investment Management Ltd

Vinva Investment Management Ltd lowered its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 53.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,675 shares of the company's stock after selling 3,110 shares during the quarter. Vinva Investment Management Ltd's holdings in Clorox were worth $437,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Public Sector Pension Investment Board raised its stake in Clorox by 12.6% during the 3rd quarter. Public Sector Pension Investment Board now owns 5,375 shares of the company's stock valued at $876,000 after buying an additional 600 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Clorox by 2.6% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 49,468 shares of the company's stock worth $8,059,000 after purchasing an additional 1,247 shares in the last quarter. CreativeOne Wealth LLC purchased a new position in shares of Clorox in the third quarter valued at about $213,000. Townsquare Capital LLC bought a new position in Clorox in the 3rd quarter worth approximately $363,000. Finally, FMR LLC increased its holdings in Clorox by 27.6% in the 3rd quarter. FMR LLC now owns 776,232 shares of the company's stock valued at $126,456,000 after acquiring an additional 168,111 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Insider Activity at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the firm's stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company's stock, valued at approximately $2,229,719.92. This trade represents a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.57% of the stock is currently owned by company insiders.

Clorox Trading Up 0.0 %

CLX stock traded up $0.02 during midday trading on Friday, hitting $167.17. 465,385 shares of the company's stock were exchanged, compared to its average volume of 1,220,052. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.35. The business has a 50-day simple moving average of $163.09 and a two-hundred day simple moving average of $149.39. The stock has a market capitalization of $20.69 billion, a PE ratio of 58.25, a P/E/G ratio of 3.09 and a beta of 0.41. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company's quarterly revenue was up 27.0% on a year-over-year basis. During the same period last year, the business posted $0.49 earnings per share. On average, sell-side analysts predict that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 2.92%. Clorox's dividend payout ratio (DPR) is presently 170.04%.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. DA Davidson upped their target price on shares of Clorox from $153.00 to $171.00 and gave the company a "neutral" rating in a research report on Monday, November 4th. JPMorgan Chase & Co. increased their target price on shares of Clorox from $148.00 to $174.00 and gave the stock a "neutral" rating in a report on Friday, October 11th. Barclays raised their price objective on Clorox from $137.00 to $139.00 and gave the company an "underweight" rating in a research report on Friday, November 1st. Citigroup upped their price target on Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a research report on Friday, September 6th. Finally, Evercore ISI dropped their target price on Clorox from $140.00 to $139.00 and set an "underperform" rating on the stock in a research note on Monday, October 14th. Five investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat, Clorox currently has a consensus rating of "Hold" and a consensus price target of $155.00.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.